دورية أكاديمية
Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
| العنوان: | Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial |
|---|---|
| المؤلفون: | Li, RogerAff1, Aff2, IDs41591024031576_cor1, Shah, Paras H., Stewart, Tyler F., Nam, Jong Kil, Bivalacqua, Trinity J., Lamm, Donald L., Uchio, Edward M., Geynisman, Daniel M., Jacob, Joseph M., Meeks, Joshua J., Dickstein, Rian, Pearce, Shane M., Kang, Seok Ho, Jung, Seung Il, Kamat, Ashish M., Burke, James M., Keegan, Kirk A.Aff18, Aff19, Steinberg, Gary D. |
| المصدر: | Nature Medicine. 30(8):2377-2377 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 10788956 1546170X |
|---|---|
| DOI: | 10.1038/s41591-024-03157-6 |